DOYLE WILLIAM F (CIK 1194459) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVCR (200,000 shares), Buy NVCR (200,284 shares), Sell NVCR (50,557 shares), Sell NVCR (21,330 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NovoCure Ltd (NVCR) | Executive Chairman | Buy | 200,000 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Executive Chairman | Buy | 200,284 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Executive Chairman | Sell | 50,557 | $646,624 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Executive Chairman | Sell | 21,330 | $286,462 |
Source: SEC Form 4 filings · as of 2026-03-05